Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Mar 2012* | Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | 1.46 | 1.54 | 1.47 | 1.46 | 1.84 |
| Reported EPS($) | 1.61 | 1.83 | 1.67 | 1.40 | NA |
| GAAP($) | 1.48 | 1.61 | 1.41 | 1.01 | NA |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | 1.84 | 1.76 | 7.21 | 8.25 |
| Number of Analysts | 21 | 20 | 26 | 26 |
| Low Estimate ($) | 1.52 | 1.64 | 6.86 | 7.45 |
| High Estimate ($) | 2.05 | 1.91 | 7.45 | 8.86 |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | 1.84 | 1.76 | 7.21 | 8.25 |
| 30 Days Ago ($) | 1.83 | 1.76 | 7.20 | 8.24 |
| 90 Days Ago ($) | 1.70 | 1.72 | 6.98 | 8.09 |
| Dec 2013* | Dec 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| AMGN | 23.42% | 9.56% | 9.33% | 14.44 | 1.53 | |
